Normal regulatory α/β T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor β in vivo

被引:79
作者
Suzuki, H
Zhou, YW
Kato, M
Mak, TW
Nakashima, I
机构
[1] Nagoya Univ, Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Amgen Inst, Toronto, ON M6G 2C1, Canada
关键词
T lymphocytes; mice; knockout; CD8(+) T lymphocytes; bone marrow transplantation; adoptive transfer;
D O I
10.1084/jem.190.11.1561
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although interleukin 2 (IL-2) has been thought to be the most important cytokine for T cell growth, animals lacking IL-2 or a component of its receptor molecules have more expanded T cells with activated memory phenotype, indicating an indispensable role for the IL-2/IL-2 receptor system in regulating the size and activity of the T cell population. In this study, we investigated the possible mechanism of abnormal expansion of activated T cells in IL-2 receptor beta chain (IL-2R beta)(-/-) mice using the systems of bone marrow transplantation and T cell transfer. Here, we show that IL-2R beta(-/-) T cells in mice reconstituted with a mixture of IL-2R beta(-/-) and IL-2R beta(+/+) bone marrow cells did not develop into an abnormally activated stage, and that already activated IL-2R beta(-/-) T cells were effectively eliminated by IL-2R beta(+/+) T cells when both cells were cotransferred to T cell-deficient host mice. This regulation and/or elimination was dependent on T cells bearing alpha/beta type T cell receptor, especially on CD8(+) T cells and independent of the Fas-Fas ligand (FasL) system. IL-2R beta(+/+) T cells that eliminated activated IL-2R beta(-/-) T cells expressed Fast, perforin, granzyme B, and tumor necrosis factor alpha/beta. These results indicate a novel function of IL-2R beta that is necessary for the induction of regulatory T cells acting to eliminate activated T cells.
引用
收藏
页码:1561 / 1571
页数:11
相关论文
共 43 条
  • [1] Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
    Asano, M
    Toda, M
    Sakaguchi, N
    Sakaguchi, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 387 - 396
  • [2] Ciubotariu R, 1998, J IMMUNOL, V161, P5193
  • [3] LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE
    COHEN, PL
    EISENBERG, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 : 243 - 269
  • [4] A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
    Groux, H
    OGarra, A
    Bigler, M
    Rouleau, M
    Antonenko, S
    deVries, JE
    Roncarolo, MG
    [J]. NATURE, 1997, 389 (6652) : 737 - 742
  • [5] CYTOTOXIC LYMPHOCYTES REQUIRE GRANZYME-B FOR THE RAPID INDUCTION OF DNA FRAGMENTATION AND APOPTOSIS IN ALLOGENEIC TARGET-CELLS
    HEUSEL, JW
    WESSELSCHMIDT, RL
    SHRESTA, S
    RUSSELL, JH
    LEY, TJ
    [J]. CELL, 1994, 76 (06) : 977 - 987
  • [6] Itoh M, 1999, J IMMUNOL, V162, P5317
  • [7] T cell vaccination induces T cell receptor Vβ-specific Qa-1-restricted regulatory CD8+ T cells
    Jiang, H
    Kashleva, H
    Xu, LX
    Forman, J
    Flaherty, L
    Pernis, B
    Braunstein, NS
    Chess, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) : 4533 - 4537
  • [8] MURINE CD8(+) T-CELLS THAT SPECIFICALLY DELETE AUTOLOGOUS CD4(+) T-CELLS EXPRESSING V-BETA-8 TCR - A ROLE OF THE Q-ALPHA-1 MOLECULE
    JIANG, H
    WARE, R
    STALL, A
    FLAHERTY, L
    CHESS, T
    PERNIS, B
    [J]. IMMUNITY, 1995, 2 (02) : 185 - 194
  • [9] CYTOTOXICITY MEDIATED BY T-CELLS AND NATURAL-KILLER-CELLS IS GREATLY IMPAIRED IN PERFORIN DEFICIENT MICE
    KAGI, D
    LEDERMANN, B
    BURKI, K
    SEILER, P
    ODERMATT, B
    OLSEN, KJ
    PODACK, ER
    ZINKERNAGEL, RM
    HENGARTNER, H
    [J]. NATURE, 1994, 369 (6475) : 31 - 37
  • [10] NORMAL CLONAL EXPANSION BUT IMPAIRED FAS-MEDIATED CELL-DEATH AND ANERGY INDUCTION IN INTERLEUKIN-2-DEFICIENT MICE
    KNEITZ, B
    HERRMANN, T
    YONEHARA, S
    SCHIMPL, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2572 - 2577